According to Bioventus's latest financial reports and stock price the company's current Operating Margin is -10.40%. At the end of 2023 the company had an Operating Margin of -23.64%.
Year | Operating Margin | Change |
---|---|---|
2023 | -23.64% | -35.96% |
2022 | -36.91% | -1776.29% |
2021 | 2.20% | -55.56% |
2020 | 4.96% | 73.95% |
2019 | 2.85% | 48.88% |
2018 | 1.91% | |
2015 | -12.60% | 169.67% |
2014 | -4.67% | -46.34% |
2013 | -8.71% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.